Physician profile
Patrick Hall
NPI 1205872850
$50,020.64
in general payments reported to CMS, 2019-2025
42 companies · $5,175 in 2025
The $5,175 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,134 · 2020: $9,021 · 2021: $2,522 · 2022: $8,619 · 2023: $12K · 2024: $3,485 · 2025: $5,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Consulting Fee: $6,000 · Travel and Lodging: $4,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,230.75 |
| Consulting Fee | $6,000.00 |
| Travel and Lodging | $4,493.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27,373.65 | 2019-2025 | General - Atherectomy, Avvigo Guidance System, General - Stents |
| Abbott Laboratories | $5,507.30 | 2019-2025 | Mitraclip, Ultreon, Jeti |
| Abiomed | $4,357.60 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $3,424.56 | 2019-2025 | Evoque, Pascal, Sapien 3 Ultra Resilia |
| Ancora Heart, INC. | $3,063.60 | 2023-2025 | Accucinch |
| Medtronic, INC. | $1,081.53 | 2021-2023 | Corevalve Evolut R |
| Shockwave Medical, INC | $1,018.03 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Pfizer INC. | $551.42 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $523.90 | 2019-2025 | |
| Amgen INC. | $330.81 | 2019-2025 | Repatha, Repatha |
| Penumbra, INC. | $294.15 | 2021-2022 | |
| Heartflow, INC. | $292.44 | 2025 | |
| Biosense Webster, INC. | $175.75 | 2019-2025 | Nuvision Ice Catheter |
| Atricure, INC. | $168.55 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Cvrx, INC. | $161.61 | 2023 | Barostim Neo System |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.